Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease

Movement Disorders

Volumn 24, Issue 9, 2009, Pages 1333-1338

  Pontone, Gregory M ^a   Williams, James R ^b   Anderson, Karen E ^c   Chase, Gary ^d   Goldstein, Susanne A ^a,e   Grill, Stephen ^a,e   Hirsch, Elaina S ^a   Lehmann, Susan ^a   Little, John T ^a,f   Margolis, Rusell L ^a   Rabins, Peter V ^a   Weiss, Howard D ^e,g   Marsh, Laura ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e Parkinson's and Movement Disorders Center of Maryland   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

Anxiety; Nonmotor symptoms; Parkinson's disease; Psychiatric disorders

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTONIA; FEMALE; GERONTOPSYCHIATRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROLOGY; ONSET AGE; PANIC; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; SEX RATIO;

AGED; AGED, 80 AND OVER; ANXIETY; ANXIETY DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PARKINSON DISEASE; PREVALENCE;

EID: 69749114803     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22611     Document Type: Article

References (39)

1. Nuti A, Ceravolo R, Piccinni A, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004;11:315-320.
2. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990;147: 217-220.
3. Siemers ER, Shekhar A, Quaid K, Dickson H. Anxiety and motor performance in Parkinson's disease. Mov Disord 1993;8:501-506.
4. Witjas T, Kaphan E, Azulay JP, et al. Nonmotor fluctuations in Parkinson's disease - frequent and disabling. Neurology 2002;59: 408-413.
5. Carod-Artal FJ, Ziomkowski S, Mourao MH, Martinez-Martin P. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. Parkinsonism Relat Disord 2008;14:102-108.
6. Lauterbach EC, Freeman A, Vogel RL. Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2004;16:29-36.
7. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinsons disease and anxiety - comorbidity with depression. Biol Psychiatry 1993;34:465-470.
8. Schiffer RB, Kurlan R, Rubin A, Boer S. Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988;145: 1020-1022.
9. Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry 2007;64:1385-1392.
10. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000;15:669-677.
11. Leentjens AF, Dujardin K, Marsh L, et al. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008;23:2015-2025.
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinsons disease - a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
13. First MB, Spitzer RL, Gibbon M, Williams J. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P). Biometrics Research 2002. New York: New York State Psychiatric Institute; 2002.
14. Leckman JF, Sholomskas D, Thompson WD, Belanger A,Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982;39:879-883.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
16. Fahn S, Marsden CD, Goldstein M, editors. Members of the UPDRS development committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease II. New York: Macmillan; 1987.
17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality 1967. Neurology 2001;57 (10 Suppl 3):S11-S26.
18. Tan LC, Lau PN, Au WL, Luo N. Validation of PDQ-8 as an independent instrument in English and Chinese. J Neurol Sci 2007;255:77-80.
19. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287:455-463.
20. Henderson R, Kurlan R, Kersun JM, Como P. Preliminary examination of the comorbidity of anxiety and depression in parkinsons disease. J Neuropsychiatry Clin Neurosci 1992;4:257-264.
21. Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003;18:646-651.
22. Bryant C, Jackson H, Ames D. The prevalence of anxiety in older adults: methodological issues and a review of the literature. J Affect Disord 2008;109:233-250.
23. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
24. Maricle RA, Nutt JG, Carter JH. Mood and anxiety fluctuation in parkinsons disease associated with levodopa infusion - preliminary findings. Mov Disord 1995;10:329-332.
25. Kummer A, Cardoso F, Teixeira AL. Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease. Mov Disord 2008;23:1739-1743.
26. Karlsson B, Klenfeldt IF, Sigstrom R, Waern M, Ostling S, Gustafson D, Skoog I. Prevalence of social phobia in nondemented elderly from a swedish population study. Am J Geriatr Psychiatry 2009;17:127-135.
27. Sullivan GM, Coplan JD, Kent JM, Gorman JM. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 1999;46:1205-1218.
28. Lorincz MT. Clinical implications of Parkinson's disease genetics. Semin Neurol 2006;26:492-498.
29. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126 (Pt 6): 1279-1292.
30. Khan NL, Jain S, Lynch JM, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005;128 (Pt 12):2786-2796.
31. Matsui H, Udaka F, Oda M, Tamura A, Kubori T, Nishinaka K, Kameyama M. Parkinson's disease following panic disorder. J Neuropsychiatry Clin Neurosci 2006;18:130.
32. Lauterbach EC, Duvoisin RC. Anxiety disorders in familial parkinsonism. Am J Psychiatry 1991;148:274.
33. Lauterbach EC. The locus ceruleus and anxiety disorders in demented and nondemented familial parkinsonism. Am J Psychiatry 1993;150:994.
34. Richard IH, Szegethy E, Lichter D, Schiffer RB, Kurlan R. Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety. Clin Neuropharmacol 1999;22: 172-175.
35. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tiss Res 2004;318:121-134.
36. Fornai F, Poggio AB, Pellegrini A, Ruggieri S, Paparelli A. Noradrenaline in Parkinson's disease: from disease progression to current therapeutics. Curr Med Chem 2007;14:2330-2334.
37. Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci Biobehav Rev 2000;24: 655-668.
38. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
39. McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson T, Fink J, Roger D. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. Parkinsonism Relat Disord 2008;14:37-42.